{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:09:13Z","timestamp":1775596153617,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10072-022-05875-6","type":"journal-article","created":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T02:02:30Z","timestamp":1642298550000},"page":"2171-2186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Neurological toll of COVID-19"],"prefix":"10.1007","volume":"43","author":[{"given":"Shivam","family":"Bhola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhillika","family":"Trisal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Kulshrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi Kant","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-8360","authenticated-orcid":false,"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,16]]},"reference":[{"key":"5875_CR1","unstructured":"(2021) WHO Coronavirus (COVID-19) Dashboard |. In: WHO. https:\/\/covid19.who.int\/. Accessed 16 Dec 2021"},{"key":"5875_CR2","doi-asserted-by":"publisher","unstructured":"Chan JF-W, Kok K-H, Zhu Z et al (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221\u2013236. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","DOI":"10.1080\/22221751.2020.1719902"},{"key":"5875_CR3","doi-asserted-by":"publisher","unstructured":"Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683\u2013690. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"5875_CR4","doi-asserted-by":"publisher","unstructured":"Jewell BL (2021) Monitoring differences between the SARS-CoV-2 B. 1.1. 7 variant and other lineages. Lancet Public Health\u00a06(5):e267\u2013e268. https:\/\/doi.org\/10.1016\/S2468-2667(21)00073-6","DOI":"10.1016\/S2468-2667(21)00073-6"},{"key":"5875_CR5","doi-asserted-by":"publisher","unstructured":"Karim SSA, Karim QA (2021) Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398(10317):2126\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(21)02758-6","DOI":"10.1016\/S0140-6736(21)02758-6"},{"key":"5875_CR6","doi-asserted-by":"publisher","unstructured":"Thakur V, Bhola S, Thakur P et al (2021) Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe. Infection 16:1\u201316. https:\/\/doi.org\/10.1007\/s15010-021-01734-2","DOI":"10.1007\/s15010-021-01734-2"},{"issue":"7798","key":"5875_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"5875_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Kok K-H, Zhu Z et al (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9:221\u2013236. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","journal-title":"Emerg Microbes Infect"},{"key":"5875_CR9","doi-asserted-by":"publisher","unstructured":"Biswas S, Thakur V, Kaur P et al (2021) Blood clots in COVID-19 patients: simplifying the curious mystery. Med Hypotheses 146:110371. https:\/\/doi.org\/10.1016\/j.mehy.2020.110371","DOI":"10.1016\/j.mehy.2020.110371"},{"issue":"2","key":"5875_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2):271\u2013280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"5875_CR11","doi-asserted-by":"publisher","unstructured":"Lukiw WJ, Pogue A, Hill JM (2022) SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol 42(1):217\u2013224. https:\/\/doi.org\/10.1007\/s10571-020-00947-7","DOI":"10.1007\/s10571-020-00947-7"},{"key":"5875_CR12","doi-asserted-by":"publisher","unstructured":"Wan Y, Shang J ,Graham R et al (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 17;94(7):e00127\u201320. https:\/\/doi.org\/10.1128\/JVI.00127-20","DOI":"10.1128\/JVI.00127-20"},{"key":"5875_CR13","doi-asserted-by":"publisher","unstructured":"Cong Y, Feng Y, Ni H, et al (2021) Anchor-Locker Binding mechanism of the coronavirus spike protein to human ACE2: insights from computational analysis. J Chem Inf Model 61, 7, 3529\u20133542. https:\/\/doi.org\/10.1021\/acs.jcim.1c00241","DOI":"10.1021\/acs.jcim.1c00241"},{"key":"5875_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1017\/cjn.2020.146","volume":"48","author":"MEV Collantes","year":"2021","unstructured":"Collantes MEV, Espiritu AI, Sy MCC et al (2021) Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci 48:66\u201376","journal-title":"Can J Neurol Sci"},{"key":"5875_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","volume":"13","author":"O Koyuncu","year":"2013","unstructured":"Koyuncu O, Hogue I, Enquist L (2013) Virus infections in the nervous system. Cell Host Microbe 13:379\u2013393","journal-title":"Cell Host Microbe"},{"key":"5875_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1183\/09031936.01.00093001","volume":"18","author":"MA Chilvers","year":"2001","unstructured":"Chilvers MA, McKean M, Rutman A et al (2001) The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J 18:965\u2013970","journal-title":"Eur Respir J"},{"key":"5875_CR17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995\u2013998","journal-title":"ACS Chem Neurosci"},{"key":"5875_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","volume":"78","author":"M Boldrini","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS (2021) How COVID-19 affects the brain. JAMA Psychiatry 78:682\u2013683","journal-title":"JAMA Psychiatry"},{"key":"5875_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","volume":"11","author":"PA Swanson II","year":"2015","unstructured":"Swanson PA II, McGavern DB (2015) Viral diseases of the central nervous system. Curr Opin Virol 11:44\u201354","journal-title":"Curr Opin Virol"},{"key":"5875_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"J Meinhardt","year":"2021","unstructured":"Meinhardt J, Radke J, Dittmayer C et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168\u2013175","journal-title":"Nat Neurosci"},{"key":"5875_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","volume":"87","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xu X, Chen Z et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18\u201322","journal-title":"Brain Behav Immun"},{"key":"5875_CR22","doi-asserted-by":"publisher","unstructured":"Poyiadji N, Shahin G, Noujaim D et al (2020) COVID-19\u2013associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology 296(2):E119\u2013E120. https:\/\/doi.org\/10.1148\/radiol.2020201187","DOI":"10.1148\/radiol.2020201187"},{"key":"5875_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370:861\u2013865","journal-title":"Science"},{"key":"5875_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01024-2","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah O, Thakur KT, Nordvig AS et al (2020) Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun 8:1\u20137","journal-title":"Acta Neuropathol Commun"},{"key":"5875_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JAD-181055","volume":"68","author":"A Wadhawan","year":"2019","unstructured":"Wadhawan A, Stiller JW, Potocki E et al (2019) Traumatic brain injury and suicidal behavior: a review. J Alzheimers Dis 68:1339\u20131370","journal-title":"J Alzheimers Dis"},{"key":"5875_CR26","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s10072-020-04486-3","volume":"41","author":"HR Niazkar","year":"2020","unstructured":"Niazkar HR, Zibaee B, Nasimi A, Bahri N (2020) The neurological manifestations of COVID-19: a review article. Neurol Sci 41:1667\u20131671","journal-title":"Neurol Sci"},{"key":"5875_CR27","doi-asserted-by":"publisher","unstructured":"Islam MA, Alam SS, Kundu S et al (2020) Prevalence of headache in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of 14,275 patients. Front Neurol 11:562634. https:\/\/doi.org\/10.3389\/fneur.2020.562634","DOI":"10.3389\/fneur.2020.562634"},{"key":"5875_CR28","first-page":"683","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. JAMA Neurol 395:683\u2013690","journal-title":"JAMA Neurol"},{"key":"5875_CR29","doi-asserted-by":"publisher","unstructured":"Zhao Z, Wei Y, Tao C (2020) An enlightening role for cytokine storm in coronavirus infection. Clin Immunol 222:108615. https:\/\/doi.org\/10.1016\/j.clim.2020.108615","DOI":"10.1016\/j.clim.2020.108615"},{"key":"5875_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-020-1021-0","volume":"20","author":"AA Divani","year":"2020","unstructured":"Divani AA, Andalib S, Biller J et al (2020) Central nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep 20:1\u201320","journal-title":"Curr Neurol Neurosci Rep"},{"key":"5875_CR31","doi-asserted-by":"publisher","unstructured":"Antoinette M, Jan DAH (2020) Headache medication and the COVID-19 pandemic. J Headache Pain 21;38. https:\/\/doi.org\/10.1186\/s10194-020-01106-5","DOI":"10.1186\/s10194-020-01106-5"},{"key":"5875_CR32","doi-asserted-by":"publisher","unstructured":"Rinott E, Kozer E, Shapira Y et al (2020) Ibuprofen use and clinical outcomes in COVID-19 patients. Clin Microbiol Infect 26(9):1259.e5\u20131259.e7. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.003","DOI":"10.1016\/j.cmi.2020.06.003"},{"key":"5875_CR33","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/head.13998","volume":"60","author":"H Bolay","year":"2020","unstructured":"Bolay H, \u00d6zge A, Ulud\u00fcz D, Baykan B (2020) Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities? Headache J Head Face Pain 60:2508\u20132521","journal-title":"Headache J Head Face Pain"},{"key":"5875_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-020-00987-5","volume":"21","author":"M Zeng","year":"2021","unstructured":"Zeng M, Wang D-Y, Mullol J, Liu Z (2021) Chemosensory dysfunction in patients with COVID-19: what do we learn from the global outbreak? Curr Allergy Asthma Rep 21:1\u20138","journal-title":"Curr Allergy Asthma Rep"},{"key":"5875_CR35","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.tmaid.2020.101875","volume":"37","author":"S Boudjema","year":"2020","unstructured":"Boudjema S, Finance J, Coulibaly F et al (2020) Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis 37:101875","journal-title":"Travel Med Infect Dis"},{"key":"5875_CR36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T et al (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol 77:1018\u20131027","journal-title":"JAMA Neurol"},{"key":"5875_CR37","doi-asserted-by":"publisher","unstructured":"Yan CH, Faraji F, Prajapati DP et al (2020) Association of chemosensory dysfunction and Covid\u201019 in patients presenting with influenza\u2010like symptoms. Int Forum Allergy Rhinol 10(7):806\u2013813. https:\/\/doi.org\/10.1002\/alr.22579","DOI":"10.1002\/alr.22579"},{"key":"5875_CR38","doi-asserted-by":"publisher","unstructured":"Vaira LA, Salzano G, Deiana G, De Riu G (2020) Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 130(7):1787. https:\/\/doi.org\/10.1002\/lary.28692","DOI":"10.1002\/lary.28692"},{"key":"5875_CR39","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s42399-020-00530-7","volume":"2","author":"M Chacko","year":"2020","unstructured":"Chacko M, Job A, Caston F et al (2020) COVID-19-induced psychosis and suicidal behavior: case Report. SN Compr Clin Med 2:2391\u20132395","journal-title":"SN Compr Clin Med"},{"key":"5875_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tim.2006.05.007","volume":"14","author":"K Subbarao","year":"2006","unstructured":"Subbarao K, Roberts A (2006) Is there an ideal animal model for SARS? Trends Microbiol 14:299\u2013303","journal-title":"Trends Microbiol"},{"key":"5875_CR41","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.psym.2020.05.012","volume":"61","author":"SJ Ferrando","year":"2020","unstructured":"Ferrando SJ, Klepacz L, Lynch S et al (2020) COVID-19 psychosis: a potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics 61:551","journal-title":"Psychosomatics"},{"key":"5875_CR42","doi-asserted-by":"publisher","first-page":"113001","DOI":"10.1016\/j.psychres.2020.113001","volume":"288","author":"M Fischer","year":"2020","unstructured":"Fischer M, Coogan AN, Faltraco F, Thome J (2020) COVID-19 paranoia in a patient suffering from schizophrenic psychosis\u2013a case report. Psychiatry Res 288:113001","journal-title":"Psychiatry Res"},{"key":"5875_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/schbul\/sbp052","volume":"37","author":"EG Severance","year":"2011","unstructured":"Severance EG, Dickerson FB, Viscidi RP et al (2011) Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull 37:101\u2013107","journal-title":"Schizophr Bull"},{"key":"5875_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3934\/Neuroscience.2016.1.67","volume":"3","author":"MR Zielinski","year":"2016","unstructured":"Zielinski MR, McKenna JT, McCarley RW (2016) Functions and mechanisms of sleep. AIMS Neurosci 3:67","journal-title":"AIMS Neurosci"},{"key":"5875_CR45","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.eclinm.2021.100916","volume":"36","author":"Z Alimoradi","year":"2021","unstructured":"Alimoradi Z, Brostr\u00f6m A, Tsang HWH et al (2021) Sleep problems during COVID-19 pandemic and its\u2019 association to psychological distress: a systematic review and meta-analysis. EClinicalMedicine 36:100916","journal-title":"EClinicalMedicine"},{"key":"5875_CR46","doi-asserted-by":"publisher","unstructured":"Yue L, Wang J, Ju M et al (2020) How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China. Gen Psychiatry 33(4):e100272. https:\/\/doi.org\/10.1136\/gpsych-2020-100272","DOI":"10.1136\/gpsych-2020-100272"},{"key":"5875_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2147\/NSS.S312037","volume":"13","author":"YN Lin","year":"2021","unstructured":"Lin YN, Liu ZR, Li SQ et al (2021) Burden of sleep disturbance during COVID-19 pandemic: a systematic review. Nat Sci Sleep 13:933","journal-title":"Nat Sci Sleep"},{"key":"5875_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, Patcai J (2011) Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 11:1\u20137","journal-title":"BMC Neurol"},{"key":"5875_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1747493020972922","volume":"16","author":"S Nannoni","year":"2021","unstructured":"Nannoni S, de Groot R, Bell S, Markus HS (2021) Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke 16:137\u2013149","journal-title":"Int J Stroke"},{"key":"5875_CR50","doi-asserted-by":"publisher","unstructured":"Merkler AE, Parikh NS, Mir S et al (2020) Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 77,11 1\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2730","DOI":"10.1001\/jamaneurol.2020.2730"},{"key":"5875_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000509581","volume":"49","author":"JD Spence","year":"2020","unstructured":"Spence JD, De Freitas GR, Pettigrew LC et al (2020) Mechanisms of stroke in COVID-19. Cerebrovasc Dis 49:451\u2013458","journal-title":"Cerebrovasc Dis"},{"key":"5875_CR52","doi-asserted-by":"publisher","unstructured":"Li Y, Li M, Wang M et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5(3):279\u2013284. https:\/\/doi.org\/10.1136\/svn-2020-000431","DOI":"10.1136\/svn-2020-000431"},{"key":"5875_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","volume":"11","author":"DC Hess","year":"2020","unstructured":"Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl Stroke Res 11:322\u2013325","journal-title":"Transl Stroke Res"},{"key":"5875_CR54","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE et al (2019) Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost 17:1989\u20131994","journal-title":"J Thromb Haemost"},{"key":"5875_CR55","doi-asserted-by":"publisher","unstructured":"Valderrama EV, Humbert K, Lord A et al (2020) Severe acute respiratory syndrome coronavirus 2 infection and ischemic stroke. Stroke 51(7):e124\u2013e127. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030153","DOI":"10.1161\/STROKEAHA.120.030153"},{"key":"5875_CR56","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.18632\/aging.103335","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Tang X, Fan H et al (2020) Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging (Albany NY) 12:10022","journal-title":"Aging (Albany NY)"},{"key":"5875_CR57","doi-asserted-by":"publisher","unstructured":"Ostovan VR, Foroughi R, Rostami M et al (2021) Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review. J Neurol 268(10):3549\u20133560. https:\/\/doi.org\/10.1007\/s00415-021-10450-8","DOI":"10.1007\/s00415-021-10450-8"},{"key":"5875_CR58","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38","journal-title":"N Engl J Med"},{"key":"5875_CR59","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/jnnp-2020-323586","volume":"91","author":"R Beyrouti","year":"2020","unstructured":"Beyrouti R, Adams ME, Benjamin L et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91:889\u2013891","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5875_CR60","doi-asserted-by":"publisher","unstructured":"Hughes C, Nichols T, Pike M et al (2020) Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 7(5):001691. https:\/\/doi.org\/10.12890\/2020_001691","DOI":"10.12890\/2020_001691"},{"key":"5875_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, Harii N, Goto J et al (2020) A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55\u201358","journal-title":"Int J Infect Dis"},{"key":"5875_CR62","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2011.09.007","volume":"45","author":"SM Kansagra","year":"2011","unstructured":"Kansagra SM, Gallentine WB (2011) Cytokine storm of acute necrotizing encephalopathy. Pediatr Neurol 45:400\u2013402","journal-title":"Pediatr Neurol"},{"key":"5875_CR63","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00415-020-10108-x","volume":"268","author":"A Guilmot","year":"2021","unstructured":"Guilmot A, Slootjes SM, Sellimi A et al (2021) Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 268:751\u2013757","journal-title":"J Neurol"},{"key":"5875_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0135-7","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson JE, Mart MF, Cunningham C et al (2020) Delirium. Nat Rev Dis Prim 6:1\u201326","journal-title":"Nat Rev Dis Prim"},{"key":"5875_CR65","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms J, Kremer S, Merdji H et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:2268\u20132270","journal-title":"N Engl J Med"},{"key":"5875_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-02882-x","volume":"24","author":"K Kotfis","year":"2020","unstructured":"Kotfis K, Roberson SW, Wilson JE et al (2020) COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care 24:1\u20139","journal-title":"Crit Care"},{"key":"5875_CR67","doi-asserted-by":"publisher","unstructured":"El\u2010Qushayri AE, Ghozy S, Reda A et al (2021) The impact of Parkinson\u2019s disease on manifestations and outcomes of Covid\u201019 patients: a systematic review and meta\u2010analysis. Rev Med Virol 14:e2278. https:\/\/doi.org\/10.1002\/rmv.2278","DOI":"10.1002\/rmv.2278"},{"key":"5875_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-017-0904-4","volume":"17","author":"G McLean","year":"2017","unstructured":"McLean G, Hindle JV, Guthrie B, Mercer SW (2017) Co-morbidity and polypharmacy in Parkinson\u2019s disease: insights from a large Scottish primary care database. BMC Neurol 17:1\u20138","journal-title":"BMC Neurol"},{"key":"5875_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.14802\/jmd.20042","volume":"13","author":"R Bhidayasiri","year":"2020","unstructured":"Bhidayasiri R, Virameteekul S, Kim J-M et al (2020) COVID-19: an early review of its global impact and considerations for Parkinson\u2019s disease patient care. J Mov Disord 13:105","journal-title":"J Mov Disord"},{"key":"5875_CR70","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"Y Li","year":"2020","unstructured":"Li Y, Bai W, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92:552\u2013555","journal-title":"J Med Virol"},{"key":"5875_CR71","doi-asserted-by":"publisher","unstructured":"Rajan S, Kaas B, Moukheiber E (2019) Movement disorders emergencies. Semin Neurol 39(1):125\u2013136. https:\/\/doi.org\/10.1055\/s-0038-1677050","DOI":"10.1055\/s-0038-1677050"},{"key":"5875_CR72","doi-asserted-by":"publisher","unstructured":"Chan JL, Murphy KA, Sarna JR (2021) Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol 268(10):3517\u20133548. https:\/\/doi.org\/10.1007\/s00415-021-10458-0","DOI":"10.1007\/s00415-021-10458-0"},{"key":"5875_CR73","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","volume":"266","author":"S-Y Oh","year":"2019","unstructured":"Oh S-Y, Kim J-S, Dieterich M (2019) Update on opsoclonus\u2013myoclonus syndrome in adults. J Neurol 266:1541\u20131548","journal-title":"J Neurol"},{"key":"5875_CR74","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangu\u00e9","year":"2016","unstructured":"Armangu\u00e9 T, Sabater L, Torres-Vega E et al (2016) Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73:417\u2013424","journal-title":"JAMA Neurol"},{"key":"5875_CR75","doi-asserted-by":"publisher","unstructured":"Wan S, Yi Q, Fan S et al (2020) Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv https:\/\/doi.org\/10.1101\/2020.02.10.20021832","DOI":"10.1101\/2020.02.10.20021832"},{"key":"5875_CR76","doi-asserted-by":"publisher","unstructured":"Chen C, Zhang XR, Ju ZY, He WF (2020) Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi 36(6):471\u2013475. Chinese. https:\/\/doi.org\/10.3760\/cma.j.cn501120-20200224-00088","DOI":"10.3760\/cma.j.cn501120-20200224-00088"},{"key":"5875_CR77","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/jcm9061651","volume":"9","author":"B Marchandot","year":"2020","unstructured":"Marchandot B, Sattler L, Jesel L et al (2020) COVID-19 related coagulopathy: a distinct entity? J Clin Med 9:1651","journal-title":"J Clin Med"},{"key":"5875_CR78","doi-asserted-by":"publisher","unstructured":"Goh Y, Beh DLL, Makmur A et al (2020) Pearls and oysters: facial nerve palsy as a neurological manifestation of Covid-19 infection. Neurology 25;95(8):364\u2013367. https:\/\/doi.org\/10.1212\/WNL.0000000000009863","DOI":"10.1212\/WNL.0000000000009863"},{"key":"5875_CR79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamaoto.2021.1266","volume":"147","author":"A Tamaki","year":"2021","unstructured":"Tamaki A, Cabrera CI, Li S et al (2021) Incidence of Bell palsy in patients with COVID-19. JAMA Otolaryngol Neck Surg 147:767\u2013768","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"5875_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03121-z","volume":"24","author":"G Nepal","year":"2020","unstructured":"Nepal G, Rehrig JH, Shrestha GS et al (2020) Neurological manifestations of COVID-19: a systematic review. Crit Care 24:1\u201311","journal-title":"Crit Care"},{"key":"5875_CR81","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1148\/rg.2020200195","volume":"40","author":"MV Revzin","year":"2020","unstructured":"Revzin MV, Raza S, Srivastava NC et al (2020) Multisystem imaging manifestations of COVID-19, part 2: from cardiac complications to pediatric manifestations. Radiographics 40:1866\u20131892","journal-title":"Radiographics"},{"key":"5875_CR82","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z et al (2020) COVID-19\u2013associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve 62:485\u2013491","journal-title":"Muscle Nerve"},{"key":"5875_CR83","doi-asserted-by":"publisher","unstructured":"Ramani SL, Samet J, Franz CK et al (2021) Musculoskeletal involvement of COVID-19: review of imaging. Skelet Radiol 50(9):1763\u20131773. https:\/\/doi.org\/10.1007\/s00256-021-03734-7","DOI":"10.1007\/s00256-021-03734-7"},{"key":"5875_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nic.2013.03.035","volume":"24","author":"S Ahlawat","year":"2014","unstructured":"Ahlawat S, Chhabra A, Blakely J (2014) Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin 24:171\u2013192","journal-title":"Neuroimaging Clin"},{"key":"5875_CR85","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235","journal-title":"J Clin Neurosci"},{"key":"5875_CR86","doi-asserted-by":"publisher","unstructured":"van Vuren EJ, Steyn SF, Brink CB et al (2021) The neuropsychiatric manifestations of COVID-19: interactions with psychiatric illness and pharmacological treatment. Biomed Pharmacother 135:111200. https:\/\/doi.org\/10.1016\/j.biopha.2020.111200","DOI":"10.1016\/j.biopha.2020.111200"},{"key":"5875_CR87","doi-asserted-by":"publisher","unstructured":"Roy D, Ghosh R, Dubey S et al (2020) Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci 48(1):9\u201324. https:\/\/doi.org\/10.1017\/cjn.2020.173","DOI":"10.1017\/cjn.2020.173"},{"key":"5875_CR88","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3389\/fpsyt.2020.581144","volume":"11","author":"D Janiri","year":"2020","unstructured":"Janiri D, Petracca M, Moccia L et al (2020) COVID-19 pandemic and psychiatric symptoms: the impact on Parkinson\u2019s disease in the elderly. Front Psychiatry 11:1306","journal-title":"Front Psychiatry"},{"key":"5875_CR89","doi-asserted-by":"crossref","unstructured":"Vittori A, Lerman J, Cascella M et al (2020) Coronavirus Disease 2019 Pandemic Acute Respiratory Distress Syndrome Survivors: Pain After the Storm? Anesth Analg 31(1):117\u2013119. 10.1213\/ANE.0000000000004914","DOI":"10.1213\/ANE.0000000000004914"},{"key":"5875_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01416-5","volume":"11","author":"Q Xie","year":"2021","unstructured":"Xie Q, Liu X-B, Xu Y-M, Zhong B-L (2021) Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the Symptom Checklist-90-Revised. Transl Psychiatry 11:1\u201310","journal-title":"Transl Psychiatry"},{"key":"5875_CR91","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297\u2013306","journal-title":"Depress Anxiety"},{"key":"5875_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-021-01237-9","volume":"23","author":"ZM Nakamura","year":"2021","unstructured":"Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL (2021) Neuropsychiatric complications of COVID-19. Curr Psychiatry Rep 23:1\u20139","journal-title":"Curr Psychiatry Rep"},{"key":"5875_CR93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fphar.2019.00023","volume":"10","author":"DM Stamenkovic","year":"2019","unstructured":"Stamenkovic DM, Laycock H, Karanikolas M et al (2019) Chronic pain and chronic opioid use after intensive care discharge\u2013is it time to change practice? Front Pharmacol 10:23","journal-title":"Front Pharmacol"},{"key":"5875_CR94","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M et al (2021) 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8:416\u2013427","journal-title":"Lancet Psychiatry"},{"key":"5875_CR95","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","volume":"7","author":"JP Rogers","year":"2020","unstructured":"Rogers JP, Chesney E, Oliver D et al (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7:611\u2013627","journal-title":"Lancet Psychiatry"},{"key":"5875_CR96","doi-asserted-by":"publisher","unstructured":"Garrigues E, Janvier P, Kherabi Y et al (2020) Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 81(6):e4\u2013e6. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.029","DOI":"10.1016\/j.jinf.2020.08.029"},{"key":"5875_CR97","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"7","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj A, Thomas N, Ellul MA et al (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7:875\u2013882","journal-title":"Lancet Psychiatry"},{"key":"5875_CR98","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/acn3.51210","volume":"7","author":"EM Liotta","year":"2020","unstructured":"Liotta EM, Batra A, Clark JR et al (2020) Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 7:2221\u20132230","journal-title":"Ann Clin Transl Neurol"},{"key":"5875_CR99","doi-asserted-by":"publisher","unstructured":"Woo MS, Malsy J, P\u00f6ttgen J et al (2020) Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2(2):fcaa205. https:\/\/doi.org\/10.1093\/braincomms\/fcaa205","DOI":"10.1093\/braincomms\/fcaa205"},{"key":"5875_CR100","first-page":"1075","volume":"21","author":"ZS Nasreddine","year":"2006","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V (2006) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. JAm Geriatr Soc 2005; 53: 695\u20139. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges J. The Addenbrooke\u2019s Cognitive Examination Revised (ACE-R): a brief cognitive. Int J Geriatr Psychiatry 21:1075\u20131078","journal-title":"Int J Geriatr Psychiatry"},{"key":"5875_CR101","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A et al (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol 63:1179\u20131194","journal-title":"J Clin Epidemiol"},{"key":"5875_CR102","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","volume":"26","author":"QQ Wang","year":"2021","unstructured":"Wang QQ, Kaelber DC, Xu R, Volkow ND (2021) COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry 26:30\u201339","journal-title":"Mol Psychiatry"},{"key":"5875_CR103","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cdip.2004.04.009","volume":"10","author":"JF Tomashefski Jr","year":"2004","unstructured":"Tomashefski JF Jr, Felo JA (2004) The pulmonary pathology of illicit drug and substance abuse. Curr Diagn Pathol 10:413\u2013426","journal-title":"Curr Diagn Pathol"},{"key":"5875_CR104","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/add.14870","volume":"115","author":"J Hulin","year":"2020","unstructured":"Hulin J, Brodie A, Stevens J, Mitchell C (2020) Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Addiction 115:832\u2013849","journal-title":"Addiction"},{"key":"5875_CR105","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1080\/10826084.2020.1791184","volume":"55","author":"J Schimmel","year":"2020","unstructured":"Schimmel J, Manini AF (2020) Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse 55:1900\u20131901","journal-title":"Subst Use Misuse"},{"key":"5875_CR106","doi-asserted-by":"publisher","unstructured":"Deng J, Zhou F, Hou W et al (2020) The prevalence of depression, anxiety, and sleep disturbances in COVID\u201019 patients: a meta\u2010analysis. Ann N Y Acad Sci 486(1):90\u2013111. https:\/\/doi.org\/10.1111\/nyas.14506","DOI":"10.1111\/nyas.14506"},{"key":"5875_CR107","first-page":"211","volume":"62","author":"C Parker","year":"2021","unstructured":"Parker C, Shalev D, Hsu I et al (2021) Depression, anxiety, and acute stress disorder among patients hospitalized with COVID-19: a prospective cohort study. J Acad Consult Psychiatry 62:211\u2013219","journal-title":"J Acad Consult Psychiatry"},{"key":"5875_CR108","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","volume":"89","author":"MG Mazza","year":"2020","unstructured":"Mazza MG, De Lorenzo R, Conte C et al (2020) Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun 89:594\u2013600","journal-title":"Brain Behav Immun"},{"key":"5875_CR109","doi-asserted-by":"publisher","first-page":"e239191","DOI":"10.1136\/bcr-2020-239191","volume":"13","author":"G Gillett","year":"2020","unstructured":"Gillett G, Jordan I (2020) Severe psychiatric disturbance and attempted suicide in a patient with COVID-19 and no psychiatric history. BMJ Case Rep 13:e239191","journal-title":"BMJ Case Rep"},{"key":"5875_CR110","doi-asserted-by":"publisher","unstructured":"Khawam E, Khouli H, Pozuelo L (2020) Treating acute anxiety in patients with COVID-19. Cleve Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc016","DOI":"10.3949\/ccjm.87a.ccc016"},{"key":"5875_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-020-01189-6","volume":"22","author":"RH Han","year":"2020","unstructured":"Han RH, Schmidt MN, Waits WM et al (2020) Planning for mental health needs during COVID-19. Curr Psychiatry Rep 22:1\u201310","journal-title":"Curr Psychiatry Rep"},{"key":"5875_CR112","doi-asserted-by":"publisher","unstructured":"Chamberlain SR, Grant JE, Trender W et al (2021) Post-traumatic stress disorder symptoms in COVID-19 survivors: online population survey. BJPsych Open 9;7(2):e47. https:\/\/doi.org\/10.1192\/bjo.2021.3","DOI":"10.1192\/bjo.2021.3"},{"key":"5875_CR113","doi-asserted-by":"publisher","unstructured":"Chang MC, Park D (2020) Incidence of post-traumatic stress disorder after coronavirus disease. In: Healthcare. Multidisciplinary Digital Publishing Institute. Healthcare (Basel) 30;8(4):373. https:\/\/doi.org\/10.3390\/healthcare8040373","DOI":"10.3390\/healthcare8040373"},{"key":"5875_CR114","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jmv.26368","volume":"93","author":"SJ Halpin","year":"2021","unstructured":"Halpin SJ, McIvor C, Whyatt G et al (2021) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 93:1013\u20131022","journal-title":"J Med Virol"},{"key":"5875_CR115","first-page":"116","volume":"4","author":"A Hafeez","year":"2020","unstructured":"Hafeez A, Ahmad S, Siddqui SA et al (2020) A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention. EJMO 4:116\u2013125","journal-title":"EJMO"},{"key":"5875_CR116","unstructured":"(2021) Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. In: FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19-0. Accessed 24 Jul 2021"},{"key":"5875_CR117","unstructured":"Healthcare C, Kft H. MEDICINAL PRODUCT FOR USE \u25a1 Name of the medicinal product for Use: Regkirona \u25a1 Active substance(s): Regdanvimab \u25a1 Pharmaceutical form: Concentrate for solution for infusion \u25a1 Route of administration: Intravenous infusion \u25a1 Strength: 60 mg\/ml 2. NAME AND"},{"key":"5875_CR118","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.7150\/ijbs.45538","volume":"16","author":"Y Yang","year":"2020","unstructured":"Yang Y, Islam MS, Wang J et al (2020) Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci 16:1708","journal-title":"Int J Biol Sci"},{"key":"5875_CR119","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12088-020-00893-4","volume":"60","author":"SKS Patel","year":"2020","unstructured":"Patel SKS, Lee J-K, Kalia VC (2020) Deploying biomolecules as anti-COVID-19 agents. Indian J Microbiol 60:263\u2013268","journal-title":"Indian J Microbiol"},{"key":"5875_CR120","doi-asserted-by":"publisher","unstructured":"Forchette L, Sebastian W, Liu T (2021) A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics. Curr Med Sci 41(6):1037\u20131051. https:\/\/doi.org\/10.1007\/s11596-021-2395-1","DOI":"10.1007\/s11596-021-2395-1"},{"key":"5875_CR121","unstructured":"(2021) COVID-19 vaccine tracker. In: RAPS. https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker. Accessed 18 Aug 2021"},{"issue":"12","key":"5875_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24285-4","volume":"121","author":"P Jalkanen","year":"2021","unstructured":"Jalkanen P, Kolehmainen P, H\u00e4kkinen HK et al (2021) (2021) COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun 121(12):1\u201311. https:\/\/doi.org\/10.1038\/s41467-021-24285-4","journal-title":"Nat Commun"},{"key":"5875_CR123","unstructured":"Sargent J, Kumar S, Buckley K et al (2021) Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response"},{"issue":"23","key":"5875_CR124","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi B, Choudhary MC, Regan J et al (2020) Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med 383(23):2291\u20132293. https:\/\/doi.org\/10.1056\/NEJMc2031364","journal-title":"N Engl J Med"},{"key":"5875_CR125","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/S41586-021-03291-Y","volume":"592","author":"K Sa","year":"2021","unstructured":"Sa K, Da C, Rp D et al (2021) SARS-CoV-2 evolution during treatment of chronic infection. Nature 592:277\u2013282. https:\/\/doi.org\/10.1038\/S41586-021-03291-Y","journal-title":"Nature"},{"issue":"4","key":"5875_CR126","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ygeno.2021.05.006","volume":"113","author":"R Wang","year":"2021","unstructured":"Wang R, Chen J, Gao K, Wei GW (2021) Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries. Genomics 113(4):2158\u20132170. https:\/\/doi.org\/10.1016\/j.ygeno.2021.05.006","journal-title":"Genomics"},{"issue":"7857","key":"5875_CR127","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier DA, De Marco A, Ferreira IATM et al (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature 593(7857):136\u2013141. https:\/\/doi.org\/10.1038\/s41586-021-03412-7","journal-title":"Nature"},{"key":"5875_CR128","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","volume":"384","author":"SA Madhi","year":"2021","unstructured":"Madhi SA, Baillie V, Cutland CL et al (2021) Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant. N Engl J Med 384:1885\u20131898","journal-title":"N Engl J Med"},{"key":"5875_CR129","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","volume":"21","author":"RK Gupta","year":"2021","unstructured":"Gupta RK (2021) Will SARS-CoV-2 variants of concern affect the promise of vaccines? Nat Rev Immunol 21:340\u2013341","journal-title":"Nat Rev Immunol"},{"key":"5875_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01957-4","volume":"17","author":"A Jarrahi","year":"2020","unstructured":"Jarrahi A, Ahluwalia M, Khodadadi H et al (2020) Neurological consequences of COVID-19: what have we learned and where do we go from here? J Neuroinflamm 17:1\u201312","journal-title":"J Neuroinflamm"},{"key":"5875_CR131","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2020","unstructured":"Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720","journal-title":"N Engl J Med"},{"key":"5875_CR132","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmi.2020.03.032","volume":"26","author":"X Wang","year":"2020","unstructured":"Wang X, Fang J, Zhu Y et al (2020) Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect 26:1063\u20131068","journal-title":"Clin Microbiol Infect"},{"key":"5875_CR133","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1164\/rccm.202002-0445OC","volume":"201","author":"Y Feng","year":"2020","unstructured":"Feng Y, Ling Y, Bai T et al (2020) COVID-19 with different severities: a multicenter study of clinical features. Am J Respir Crit Care Med 201:1380\u20131388","journal-title":"Am J Respir Crit Care Med"},{"key":"5875_CR134","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1111\/ejn.15159","volume":"53","author":"G Travi","year":"2021","unstructured":"Travi G, Rossotti R, Merli M et al (2021) Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci 53:2912\u20132922","journal-title":"Eur J Neurosci"},{"key":"5875_CR135","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"CM Romero-S\u00e1nchez","year":"2020","unstructured":"Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Fern\u00e1ndez-D\u00edaz E et al (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95:e1060\u2013e1070","journal-title":"Neurology"},{"key":"5875_CR136","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jinf.2020.02.018","volume":"80","author":"S Tian","year":"2020","unstructured":"Tian S, Hu N, Lou J et al (2020) Characteristics of COVID-19 infection in Beijing. J Infect 80:401\u2013406","journal-title":"J Infect"},{"key":"5875_CR137","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/gerona\/glaa089","volume":"75","author":"T Chen","year":"2020","unstructured":"Chen T, Dai Z, Mo P et al (2020) Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study. J Gerontol Ser A 75:1788\u20131795","journal-title":"J Gerontol Ser A"},{"key":"5875_CR138","doi-asserted-by":"publisher","unstructured":"Du R-H, Liang L-R, Yang C-Q et al (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 7;55(5):2000524. https:\/\/doi.org\/10.1183\/13993003.00524-2020","DOI":"10.1183\/13993003.00524-2020"},{"key":"5875_CR139","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA 323:1061\u20131069","journal-title":"JAMA"},{"key":"5875_CR140","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s10072-020-04547-7","volume":"41","author":"\u00d6 Karada\u015f","year":"2020","unstructured":"Karada\u015f \u00d6, \u00d6zt\u00fcrk B, Sonkaya AR (2020) A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci 41:1991\u20131995","journal-title":"Neurol Sci"},{"key":"5875_CR141","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/cid\/ciaa199","volume":"71","author":"J Wu","year":"2020","unstructured":"Wu J, Liu J, Zhao X et al (2020) Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis 71:706\u2013712","journal-title":"Clin Infect Dis"},{"key":"5875_CR142","doi-asserted-by":"publisher","first-page":"116969","DOI":"10.1016\/j.jns.2020.116969","volume":"415","author":"P Pinna","year":"2020","unstructured":"Pinna P, Grewal P, Hall JP et al (2020) Neurological manifestations and COVID-19: experiences from a tertiary care center at the frontline. J Neurol Sci 415:116969","journal-title":"J Neurol Sci"},{"key":"5875_CR143","doi-asserted-by":"publisher","unstructured":"Wu J, Wu X, Zeng W et al (2020) Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest Radiol 55(5):257\u2013261. https:\/\/doi.org\/10.1097\/RLI.0000000000000670","DOI":"10.1097\/RLI.0000000000000670"},{"key":"5875_CR144","doi-asserted-by":"publisher","unstructured":"Kim ES, Chin BS, Kang CK et al (2020) Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean cohort study on COVID-19. J Korean Med Sci 6;35(13):e142. https:\/\/doi.org\/10.3346\/jkms.2020.35.e142","DOI":"10.3346\/jkms.2020.35.e142"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-05875-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-05875-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T03:50:26Z","timestamp":1666669826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-05875-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,16]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5875"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-05875-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,16]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}